수신증 시장 규모, 점유율, 성장 분석 : 유형별, 적응증별, 진단별, 치료법별, 연령층별, 지역별 - 산업 예측(2025-2032년)

Global Hydronephrosis Market size was valued at USD 2.3 billion in 2023 and is poised to grow from USD 2.42 billion in 2024 to USD 3.6 billion by 2032, growing at a CAGR of 5.1% during the forecast period (2025-2032).

The rising incidence of urinary tract obstructions, such as kidney stones, congenital anomalies, and tumors, is significantly influencing the global hydronephrosis market. These conditions hinder urine flow, leading to kidney swelling and deterioration, which prompts patients to seek diagnostic and therapeutic options, including minimally invasive techniques and surgical interventions. Contributing factors like lifestyle changes, dietary habits, and aging populations are intensifying the demand for advanced hydronephrosis management solutions worldwide. Concurrently, the proliferation of sophisticated imaging technologies, such as ultrasound, CT scans, and MRI, enables precise, non-invasive examination of kidney structures. This permits early diagnosis and appropriate intervention, minimizing complications and enhancing patient outcomes. The accessibility of affordable imaging devices further bolsters this market, driving growth and attracting investment opportunities.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Hydronephrosis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Hydronephrosis Market Segments Analysis

Global Hydronephrosis Market is segmented by Type, Indication, Diagnosis, Treatment, Age Group and region. Based on Type, the market is segmented into Unilateral hydronephrosis and Bilateral hydronephrosis. Based on Indication, the market is segmented into Intrinsic and Extrinsic. Based on Diagnosis, the market is segmented into Laboratory tests and Imaging. Based on Treatment, the market is segmented into Shock wave lithotripsy, Laparoscopy, Bladder catheterization, Steroid therapy and Other treatment types. Based on Age Group, the market is segmented into Adult and Pediatric. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Hydronephrosis Market

The global hydronephrosis market is significantly driven by the rising prevalence of urinary tract obstructions such as kidney stones, congenital disorders, and tumors. These medical issues result in urine buildup, kidney enlargement, and compromised renal function, leading to an increased demand for innovative diagnostic technologies and efficient treatment options. As healthcare systems strive to address these challenges, the need for cutting-edge solutions continues to propel market expansion on a global scale. The heightened awareness and focus on managing hydronephrosis further contribute to the growth trajectory of this market segment, emphasizing the importance of timely intervention and advanced care strategies.

Restraints in the Global Hydronephrosis Market

The Global Hydronephrosis market faces significant constraints due to the lack of public awareness regarding kidney disorders in many developing countries, coupled with the limited access to early screening programs. This deficiency in awareness often leads to delayed diagnoses, which in turn undermines the effectiveness of treatments for hydronephrosis. As timely detection is crucial for optimal intervention, the resulting decrease in treatment efficacy restricts the demand for advanced diagnostic and therapeutic options. Consequently, these factors pose considerable challenges to market growth and expansion in these underserved regions, limiting the overall progress of the Hydronephrosis market on a global scale.

Market Trends of the Global Hydronephrosis Market

The Global Hydronephrosis market is witnessing a notable trend towards enhanced pediatric focus, particularly in addressing congenital urinary tract obstructions. Advances in AI-assisted imaging and early screening methodologies are revolutionizing detection capabilities, allowing for timely and accurate interventions in infants and children. This heightened emphasis on pediatric care not only fosters improved long-term kidney health outcomes but also broadens the spectrum of specialized treatment options available. Consequently, this trend is generating significant market opportunities for innovative diagnostic and therapeutic solutions tailored specifically for the pediatric population, elevating the overall growth potential within the hydronephrosis market landscape.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Hydronephrosis Market Size by Type & CAGR (2025-2032)

• Market Overview
• Unilateral hydronephrosis
• Bilateral hydronephrosis

Global Hydronephrosis Market Size by Indication & CAGR (2025-2032)

• Market Overview
• Intrinsic
  • Acute unilateral obstructive uropathy
  • Kidney stone
  • Bladder cancer
  • Bladder stones
  • Urethral stricture
  • Pelvic organ prolapses
  • Other intrinsic indications
• Extrinsic
  • Retroperitoneal fibrosis
  • Ovarian vein syndrome
  • Other extrinsic indications

Global Hydronephrosis Market Size by Diagnosis & CAGR (2025-2032)

• Market Overview
• Laboratory tests
  • Urinalysis
  • Complete blood count
  • Electrolyte analysis
  • Other laboratory tests
• Imaging
  • Ultrasound
  • Intravenous pyelography
  • KUB X-Rays
  • CT-scan
  • Other imaging types

Global Hydronephrosis Market Size by Treatment & CAGR (2025-2032)

• Market Overview
• Shock wave lithotripsy
• Laparoscopy
• Bladder catheterization
• Steroid therapy
• Other treatment types

Global Hydronephrosis Market Size by Age Group & CAGR (2025-2032)

• Market Overview
• Adult
• Pediatric

Global Hydronephrosis Market Size & CAGR (2025-2032)

• North America (Type, Indication, Diagnosis, Treatment, Age Group)
  • US
  • Canada
• Europe (Type, Indication, Diagnosis, Treatment, Age Group)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Indication, Diagnosis, Treatment, Age Group)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Indication, Diagnosis, Treatment, Age Group)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Indication, Diagnosis, Treatment, Age Group)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Fresenius Medical Care AG & Co. KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter International Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson MedTech (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic PLC (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Olympus Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Intuitive Surgical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Coloplast A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teleflex Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• KARL STORZ SE & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dornier MedTech (Germany/USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nipro Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Asahi Kasei Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Convatec Group PLC (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Richard Wolf GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations